Order OPDIVO (Nivolumab) 40mg/4mL online

OPDIVO is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of advanced Lung Cancer, Melanoma, advanced Kidney Cancer, Head and Neck Squamous Cell Cancer, Advanced Liver Cancer, Advanced Bladder Cancer, Colorectal Cancer and Classical Hodgkin Lymphoma.

866.00 per Vial